Banner
Social Media Is A Faster Source For Unemployment Data Than Government

Government unemployment data today are what Nielsen TV ratings were decades ago - a flawed metric...

Gestational Diabetes Up 36% In The Last Decade - But Black Women Are Healthiest

Gestational diabetes, a form of glucose intolerance during pregnancy, occurs primarily in women...

Object-Based Processing: Numbers Confuse How We Perceive Spaces

Researchers recently studied the relationship between numerical information in our vision, and...

Males Are Genetically Wired To Beg Females For Food

Bees have the reputation of being incredibly organized and spending their days making sure our...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

The Basque Institute of Agricultural Research and Development Neiker-Tecnalia is currently exploring a strategy to remedy soils contaminated by organic compounds containing chlorine (organochlorine compounds). The innovative process consists of combining the application of zero-iron nanoparticles with bioremediation techniques. The companies Ekotek and Dinam, the UPV/EHU-University of the Basque Country and Gaiker-IK4 are also participating in this project known as NANOBIOR.

Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor vessel healing, leading to vessel graft occlusion. To improve the outcome of bypasses, researchers from the University of Geneva (UNIGE) work together with medical doctors from the Lausanne University Hospital (CHUV). They developed a gel containing microparticles -'GeM', enabling the controlled release of a drug inhibiting cellular over-proliferation. Administered locally, directly on the bypass graft during surgery, this preventive treatment will reduce the risk of obstruction reoccurrence. This research can be read in The Journal of Controlled Release.

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.

Inotuzumab ozogamicin, also known as CMC-544, links an antibody that targets CD22, a protein found on the surface of more than 90 percent of ALL cells. Once the drug connects to CD22, the ALL cell draws it inside and dies.

It's no surprise that the rise of peanut allergies correlates to the rise in helicopter parenting. Where kids once built up immunity by getting dirty and eating the foods their parents, a subset of modern parents schedule play dates, buy antibacterial soap and believe that breast milk has "otherworldly power."

The frequency of nuisance tidal flooding in many U.S. cities was predicted for the 2015 meteorological year, from May 2015 to April 2016, according to a new NOAA report.

Simon Fraser University research aimed at helping people get to sleep will be highlighted at an international sleep conference next week. Luc Beaudoin, an adjunct professor in cognitive science and education, created the mySleepButton® app two years ago (a new version with the world's first configurable "body scan" will be released shortly).

It uses what he calls a "cognitive shuffle," or Serial Diverse Imagining (SDI), a method that essentially "scrambles" one's thoughts and keeps the mind off issues that may prevent sleep. "A racing mind, worries and uncontrollable thoughts are common bedtime complaints among poor sleepers," Beaudoin notes.